Christie Thomas, MD
Rheumatology · Huntsville, ALNPI 1073725875
Payments from drug & device makers
Across 761 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Amgen$1K
- UCB, Inc.$1K
- Novartis$1K
- Johnson & Johnson$1K
- GSK$883
- plus $4K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 168 | $3,128 |
| Amgen(2 entities) | 83 | $1,374 |
| UCB, Inc. | 103 | $1,349 |
| Novartis | 87 | $1,115 |
| Johnson & Johnson(2 entities) | 58 | $1,025 |
| GSK | 46 | $883 |
| E.r. Squibb & Sons, L.L.C. | 71 | $866 |
| AstraZeneca | 21 | $495 |
| Pfizer | 38 | $483 |
| Genentech USA, Inc. | 20 | $225 |
| Boehringer Ingelheim | 9 | $216 |
| Fresenius Kabi USA, LLC | 13 | $209 |
| Bristol Myers Squibb | 3 | $161 |
| Abiomed | 1 | $113 |
| Radius Health, Inc. | 7 | $113 |
| Mallinckrodt Hospital Products Inc. | 2 | $74 |
| Scilex Pharmaceuticals Inc. | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 4 | $61 |
| Sanofi | 2 | $49 |
| Mallinckrodt Enterprises LLC | 2 | $49 |
| Actelion Pharmaceuticals US, Inc. | 4 | $47 |
| Aurinia Pharma U.S., Inc. | 2 | $42 |
| Lilly USA, LLC | 3 | $41 |
| Janssen Scientific Affairs, LLC | 1 | $40 |
| Mylan Institutional Inc. | 1 | $24 |
| Organon | 1 | $22 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $21 |
| Octapharma USA, Inc. | 1 | $21 |
| Sobi, Inc | 1 | $17 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $15 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $14 |
| Celltrion USA Inc. | 1 | $13 |
| Medexus Pharma, Inc. | 1 | $11 |
How this compares
$12,396 in reported general payments places this provider in the 55th percentile of 90 rheumatology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other rheumatology in Huntsville
- William ShergyHuntsville$453K
- Kun ChenHuntsville$22K
- Deepak SreeHuntsville$17K
- Ayesha JaleelHuntsville$14K
- Margaret MeehanHuntsville$13K
- Roxanna SabghiHuntsville$11K
- Robert PhillipsHuntsville$7K
- Elijah MitchamHuntsville$5K
- Jeffrey CurtisBirmingham$17.6M
- Kenneth SaagBirmingham$8.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.